Jaguar Health (JAGX) Restructuring Costs (2019)
Jaguar Health's (JAGX) quarterly Restructuring Costs came in at $9000.0 in Q4 2019, down 98.59% on a QoQ basis from $640000.0 in Q3 2019.
Jaguar Health (JAGX) Restructuring Costs (2019) Analysis & Trends
Jaguar Health (JAGX) has 1 years of Restructuring Costs data on file, last reported at $9000.0 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Nanobiotix | 1,785.82 Bn | 1,785.76 Bn | - |
| 2 | Akari Therapeutics | 979.03 Bn | 979.03 Bn | - |
| 3 | BeOne Medicines | 473.10 Bn | 468.30 Bn | 1.35 Bn |
| 4 | Vertex Pharmaceuticals | 123.66 Bn | 116.41 Bn | 2.59 Bn |
| 5 | Regeneron Pharmaceuticals | 71.51 Bn | 62.75 Bn | 3.31 Bn |
| 6 | Belite Bio | 62.17 Bn | 62.17 Bn | - |
| 7 | Argenx Se | 54.65 Bn | 49.47 Bn | 1.41 Bn |
| 8 | Alnylam Pharmaceuticals | 38.18 Bn | 35.17 Bn | 959.66 Mn |
| 9 | Revolution Medicines | 36.24 Bn | 36.24 Bn | - |
| 10 | Jaguar Health | 531,261.63 | -9.53 Mn | 19.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 9,000.00 |
| Sep 30, 2019 | 640,000.00 |